The Role of Laparoscopic Mini-Gastric Bypass in Management of Metabolic Syndrome

Diabetes Metab Syndr. 2018 Jul;12(4):491-495. doi: 10.1016/j.dsx.2018.03.010. Epub 2018 Mar 16.

Abstract

Objective: The study was performed to evaluate the technique of laproscopic minigastric bypass for metabolic syndrome patients.

Study design: The patients were enrolled in a combined prospective study and had a retrospectively gathered outcome analysis.

Patient and methods: The study includes thirty patients; 24 females and 6 males suffering from metabolic syndrome with a mean age of 33.15 ± 10.17 years (range, 20-59), who fulfilled the criteria for bariatric surgery with BMI >35 with associated co-morbidities, all patients underwent laparoscopic mini-gastric bypass.

Results: BMI and WC were significantly reduced post-operatively; also co-morbidities as DM, hypertension and dyslipidemia were resolved or controlled. The mean operative time was 90 ± 12.6 min (range, 80-120). No mortality was reported within 30 days of surgery.

Conclusion: Laparoscopic mini gastric bypass is an effective procedure for the treatment of obesity, HTN, type 2 DM and dyslipidemia, technically feasible, safe operation with a low rate of major postoperative complications.

Keywords: DM; Metabolic syndrome; Mimigastric bypass.

MeSH terms

  • Adult
  • Body Mass Index
  • Disease Management
  • Female
  • Follow-Up Studies
  • Gastric Bypass / methods*
  • Gastroplasty
  • Humans
  • Laparoscopy / methods*
  • Male
  • Metabolic Syndrome / prevention & control*
  • Metabolic Syndrome / surgery
  • Middle Aged
  • Postoperative Complications*
  • Prospective Studies
  • Retrospective Studies
  • Treatment Outcome
  • Young Adult